Vilspox 50 mg/1000 mg filmom obložene tablete
| Name | Vilspox 50 mg/1000 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-932625631 |
| Active Substance | vildagliptin metforminklorid |
| Composition | svaka filmom obložena tableta sadrži 50 mg vildagliptina i 1000 mg metforminklorida (što odgovara 780 mg metformina) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Novartis Pharma GmbH, Nürnberg, Njemačka Salutas Pharma GmbH, Barleben, Njemačka Lek Pharmaceuticals d.d., Lendava, Slovenija Novartis Pharmaceutical Manufacturing LLC, Ljubljana, Slovenija Novartis Farmacéutica S.A., Barcelona, Španjolska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.12.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/130 |
| Registration Number | 381-12-01/70-22-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD08 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
